Evidence map›Paper›PMID 27751767›Full record

ReviewMolecular and cellular endocrinology2017

Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.

Koshiro Nishimoto, Minae Koga, Tsugio Seki, Kenji Oki, Elise P Gomez-Sanchez, Celso E Gomez-Sanchez, Mitsuhide Naruse, Tomokazu Sakaguchi, Shinya Morita, Takeo Kosaka and 8 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06597630 (Pathological Type,Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism,A Prospective Study), which is not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06597630 recruitingnot on this mapstarted 2023, after this paper: background citation

Pathological Type,Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism,A Prospective Study

TypeobservationalSponsorQifu LiRan2023 to 2024Enrolled100ConditionsPrimary AldosteronismArmsTissue specimens were stained by histopathology of hematoxylin-eosin
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Subclinical primary aldosteronism.Archives of endocrinology and metabolism · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Primary Aldosteronism: State-of-the-Art Review.American journal of hypertension · 2022
    Article
  9. Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution.The Journal of clinical endocrinology and metabolism · 2022
    Article
  10. Review
  11. Review
  12. Review
  13. International journal of molecular sciences · 2021
    Article
  14. Development of [Journal of medicinal chemistry · 2021
    Article
  15. Review
  16. Review
  17. Pathogenesis and treatment of primary aldosteronism.Nature reviews. Endocrinology · 2020
    Review
  18. Review
  19. Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2020
    Review
  20. The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 2 countries.

Koshiro NishimotoDepartment of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka 350-1241, Japan; Department of Biochemistry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Electronic address: k.nishimoto@keio.jp.
Minae KogaEndocrinology & Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan.
Tsugio SekiDepartment of Medical Education, School of Medicine, California University of Science and Medicine, 1405 West Valley Blvd #101, Colton, CA 92324, USA.
Kenji OkiDepartment of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Elise P Gomez-SanchezDepartment of Pharmacology & Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Celso E Gomez-SanchezEndocrinology Section, G.V. (Sonny) Montgomery VA Medical Center and University of Mississippi Medical Center, Jackson, MS 39216, USA.
Mitsuhide NaruseDepartment of Endocrinology, Metabolism and Hypertension, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.
Tomokazu SakaguchiDepartment of Surgery, Misato Kenwa Hospital, 4-494-1 Takano, Misato, Saitama 341-8555, Japan.
Shinya MoritaDepartment of Urology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Takeo KosakaDepartment of Urology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Mototsugu OyaDepartment of Urology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Tadashi OgishimaDepartment of Chemistry, Faculty of Sciences, Kyushu University, Fukuoka 819-0395, Japan.
Masanori YasudaDepartment of Pathology, Saitama Medical University International Medical Center, Hidaka 350-1241, Japan.
Makoto SuematsuDepartment of Biochemistry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Yasuaki KabeDepartment of Biochemistry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Masao OmuraEndocrinology & Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan.
Tetsuo NishikawaEndocrinology & Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan.
Kuniaki MukaiDepartment of Biochemistry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; Department of Medical Education Center, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Keio University Hospital · JPYokohama Rosai Hospital · JPUniversity of Mississippi Medical Center · USHiroshima University · JPKeio University · JPKyoto Medical Center · JPKyushu University · JPMiwa Hospital · JPSaitama Medical University · JP

Funding

ROLE OF MINERALOCORTICOIDS IN LOW-RENIN HYPERTENSIONR01HL027255 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI GOMEZ-SANCHEZ, CELSO ENRIQUE · 1985 to 2017
$3.9M
NHLBI NIH HHS R01 HL027255
6 · The paper itself

Abstract

Our group previously purified human and rat aldosterone synthase (CYP11B2 and Cyp11b2, respectively) from their adrenals and verified that it is distinct from steroid 11β-hydroxylase (CYP11B1 or Cyp11b1), the cortisol- or corticosterone-synthesizing enzyme. We now describe their distributions immunohistochemically with specific antibodies. In rats, there is layered functional zonation with the Cyp11b2-positive zona glomerulosa (ZG), Cyp11b1-positive zona fasciculata (ZF), and Cyp11b2/Cyp11b1-negative undifferentiated zone between the ZG and ZF. In human infants and children (<12 years old), the functional zonation is similar to that in rats. In adults, the adrenal cortex remodels and subcapsular aldosterone-producing cell clusters (APCCs) replace the continuous ZG layer. We recently reported possible APCC-to-APA transitional lesions (pAATLs) in 2 cases of unilateral multiple adrenocortical micro-nodules. In this review, we present 4 additional cases of primary aldosteronism, from which the extracted adrenals contain pAATLs, with results of next generation sequencing for these lesions. Immunohistochemistry for CYP11B2 and CYP11B1 has become an important tool for the diagnosis of and research on adrenocortical pathological conditions and suggests that APCCs may be the origin of aldosterone-producing adenoma.

Indexed as

AldosteroneAnimalsBiocatalysisCytochrome P-450 CYP11B2High-Throughput Nucleotide SequencingHumansHyperaldosteronismImmunohistochemistryAldosteroneCytochrome P-450 CYP11B2Aldosterone-producing cell cluster (APCC)Aldosterone synthase (CYP11B2)Human adrenalImmunohistochemistryPossible APCC-to-APA transitional lesion (pAATL)Rat adrenal

Identifiers

PMID27751767
PMCPMC5470036
OpenAlexW2536112776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.